Ra Capital Management as of Dec. 31, 2018
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 25 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Wave Life Sciences (WVE) | 18.4 | $316M | 7.5M | 42.04 | |
| Ascendis Pharma A S (ASND) | 15.5 | $266M | 4.2M | 62.65 | |
| Synthorx | 9.8 | $169M | 9.7M | 17.38 | |
| Zogenix | 5.1 | $87M | 2.4M | 36.46 | |
| BioCryst Pharmaceuticals (BCRX) | 5.0 | $86M | 11M | 8.07 | |
| Orchard Therapeutics Plc ads | 4.4 | $76M | 4.8M | 15.73 | |
| Inflarx Nv (IFRX) | 4.4 | $76M | 2.1M | 36.37 | |
| Solid Biosciences | 4.2 | $72M | 2.7M | 26.80 | |
| Myovant Sciences | 3.5 | $61M | 3.7M | 16.41 | |
| Eidos Therapeutics | 3.5 | $59M | 2.2M | 27.38 | |
| Crinetics Pharmaceuticals In (CRNX) | 3.3 | $56M | 1.9M | 29.99 | |
| Rhythm Pharmaceuticals (RYTM) | 3.0 | $52M | 2.0M | 26.88 | |
| Immunomedics | 2.5 | $43M | 3.0M | 14.27 | |
| Arvinas Ord (ARVN) | 2.4 | $40M | 3.1M | 12.85 | |
| Ra Pharmaceuticals | 2.0 | $34M | 4.9M | 6.99 | |
| Tg Therapeutics (TGTX) | 2.0 | $34M | 8.2M | 4.10 | |
| Kalvista Pharmaceuticals (KALV) | 1.7 | $29M | 1.4M | 19.75 | |
| Momenta Pharmaceuticals | 1.6 | $28M | 2.6M | 11.04 | |
| Dicerna Pharmaceuticals | 1.5 | $26M | 2.5M | 10.69 | |
| Eiger Biopharmaceuticals | 1.4 | $25M | 2.4M | 10.16 | |
| Iovance Biotherapeutics (IOVA) | 1.4 | $24M | 2.7M | 8.85 | |
| Moderna (MRNA) | 1.4 | $23M | 1.5M | 15.27 | |
| Kala Pharmaceuticals | 1.3 | $22M | 4.5M | 4.89 | |
| Scpharmaceuticals (SCPH) | 0.6 | $11M | 2.9M | 3.76 | |
| Proteon Therapeutics | 0.2 | $3.0M | 1.3M | 2.27 |
